Enveric Biosciences Inc. (ENVB) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Enveric Biosciences Inc.

    NASDAQ: ENVB · Real-Time Price · USD
    0.89
    -0.02 (-2.20%)
    At close: Sep 08, 2025, 12:18 PM

    Enveric Biosciences Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 2.24M 2.29M 17.72M 17.36M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 n/a n/a -0.00 -0.00
    Receivables
    		 n/a 224.61K n/a n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 n/a 567.6K 708.05K 380.84K
    Total Current Assets
    		 2.73M 3.58M 18.43M 17.74M
    Property-Plant & Equipment
    		 305.78K 507.38K 741.3K 470.73K
    Goodwill & Intangibles
    		 42.18K 210.93K 379.69K 8.51M
    Total Long-Term Assets
    		 347.96K 718.31K 1.12M 8.98M
    Total Assets
    		 3.08M 4.3M 19.55M 26.72M
    Account Payables
    		 521.75K 1.22M 463.27K 683.39K
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a 63.82K 107.44K
    Other Current Liabilities
    		 3.09K 350.72K 1.7M -107.44K
    Total Current Liabilities
    		 1.49M 2.34M 4M 2.08M
    Long-Term Debt
    		 n/a n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a 653.67K
    Total Long-Term Liabilities
    		 n/a n/a 527.1K 2.33M
    Total Liabilities
    		 1.49M 2.34M 4M 4.41M
    Total Debt
    		 n/a n/a 63.82K 176.3K
    Common Stock
    		 6.78K 27.39K 20.78K 325.79K
    Retained Earnings
    		 -106.07M -96.5M -79.21M -60.74M
    Comprehensive Income
    		 -594.52K -569.75K -536.73K -30.8K
    Shareholders Equity
    		 1.59M 1.96M 14.67M 22.31M
    Total Investments
    		 n/a 1.82M n/a n/a

    Add to Watchlist